STEK
Stemtech Corporation
0.0014
-0.0002-12.5%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
204.65K
P/E (TTM)
-
Basic EPS (TTM)
-0.02
Dividend Yield
0%

Recent Filings

About 

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and Collect One brand name, as well as Cellect One shield hypochlorous acid skin care product. It serves through independent distributors Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

CEO
Mr. Charles S. Arnold
IPO
11/26/2021
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic